This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Tamsulosin Hydrochloride

Read time: 1 mins
Marketing start date: 22 Nov 2024
...
 

Summary of product characteristics


Effective Time

20221031

Version

8

Spl Product Data Elements

Tamsulosin Hydrochloride Tamsulosin Hydrochloride TAMSULOSIN HYDROCHLORIDE TAMSULOSIN D&C YELLOW NO. 10 FD&C BLUE NO. 1 FD&C RED NO. 40 FD&C YELLOW NO. 6 FERRIC OXIDE YELLOW METHACRYLIC ACID POLYSORBATE 80 GELATIN TALC TITANIUM DIOXIDE TRIACETIN FERROSOFERRIC OXIDE CELLULOSE, MICROCRYSTALLINE GREEN PEACH CAPSULE ZA;18;0;4mg

Application Number

ANDA078225

Brand Name

Tamsulosin Hydrochloride

Generic Name

Tamsulosin Hydrochloride

Product Ndc

65841-695

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-695-01 in bottle of 100 Capsules Tamsulosin Hydrochloride Capsules USP, 0.4 mg R x only 100 Capsules tamsulosin hcl capsules, 0.4 mg

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.